Saturday, July 11, 2026

Drug profile · INN

propyliodone

propyliodone (DIONOSIL AQUEOUS) is an FDA-listed pharmaceutical active ingredient. Route of administration: intratracheal. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — propyliodone
US status
approved
Class
Route
INTRATRACHEAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

propyliodone (DIONOSIL AQUEOUS) is an FDA-listed pharmaceutical active ingredient. Route of administration: intratracheal. Current US regulatory status: approved.

Key facts

INN propyliodone
Brand DIONOSIL AQUEOUS
Route INTRATRACHEAL
Formulation SUSPENSION

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is propyliodone?

propyliodone (DIONOSIL AQUEOUS) is an FDA-listed pharmaceutical active ingredient. Route of administration: intratracheal. Current US regulatory status: approved.

What is the brand name for propyliodone?

DIONOSIL AQUEOUS is a marketed brand name for propyliodone. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of propyliodone?

propyliodone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.